Click on image to view larger version.

Figure 1 Bar graph demonstrating angiographic restenosis rates at six months and clinical restenosis rates at one year (need for target lesion revascularization [TLR], repeat coronary intervention, or bypass surgery). White bars = placebo; black bars = imatinib.